Clinical and Laboratory Standards Institute document I/LA30-P – Immunoassay Interference by Endogenous Antibodies; Proposed Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.
CLSI I/LA30-P:2007
Original price was: $144.89.$72.00Current price is: $72.00.
Immunoassay Interference by Endogenous Antibodies; Proposed Guideline, ILA30PE
Clinical and Laboratory Standards Institute , 03/01/2007
Pages: 40
